ArticleJournal of microbiology and biotechnology2025
Botulinum Neurotoxin Type A Combined with Platelet-Rich Plasma Promotes Hair Follicle Growth and Regeneration via STMN1 Modulation and Wnt/β-Catenin Pathway Activation.
Article in Journal of microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is currently limited knowledge about the combined effect of Botulinum toxin type A (BoNT/A) and Platelet-rich plasma (PRP) on hair follicle growth and reconstruction. This study aimed to investigate the impact of BoNT/A in conjunction with PRP on hair follicles and explore its underlying mechanisms. The levels of alkaline phosphatase (ALP), fibroblast growth factor (FGF), platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and versican levels were assessed to determine their influence on hair follicle growth. Hair follicle quantification was performed, while β-catenin and Ki-67 expression levels were analyzed. The concentrations of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) were measured as inflammatory biomarkers. Western blot analysis measured stathmin 1 (STMN1) expression and quantified key Wnt/β-catenin signaling pathway components. The findings demonstrated that the conjunction of BoNT/A and PRP effectively enhanced hair follicle growth. It promoted the upregulation of ALP, FGF, PDGF, VEGF, and versican, increased hair follicle number, upregulated ALP levels, and enhanced the expression of β-catenin and Ki-67. It also markedly decreased the concentrations of IL-6 and TNF-α, potentially inhibiting hair follicle miniaturization by mitigating inflammation. The combined treatment promotes hair follicle growth by activating the Wnt/β-catenin pathway through STMN1 upregulation. BoNT/A in conjunction with PRP facilitates hair follicle growth and reconstruction through STMN1 protein modulation and Wnt/β-catenin pathway activation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.